Delivery Order SPE2DB22D1052-SPE2DB25FV0BD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $59,361.43 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick pharmaceutical product. The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed pricing with no set-aside designation. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle, with performance to be fulfilled at the company's Conshohocken,...
- The Defense Logistics Agency awarded a $41,759.43 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $3,874.93 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease management. This firm fixed-price delivery order, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The contract contains no set-aside designation and involves...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,016.82 to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to supply REPATHA 140 MG/ML SURECLICK medication. This order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 between DLA and AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA...
- The Defense Logistics Agency awarded a $4,247.74 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick medication on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $12,889.99 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 5, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to the pharmaceutical distributor and represents a continuation of the company's ongoing supply relationship with DLA. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $53,634.27 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,254.40 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick auto-injectors. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed price delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and serves as a...
- The Defense Logistics Agency awarded a $4,761.52 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick, a PCSK9 inhibitor used in cardiovascular disease management. This contract, awarded on July 18, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $1,041.42. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FV0BDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,919.67 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick, a pharmaceutical product, with performance in Conshohocken, Pennsylvania. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and carries an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products, medications, vaccines, and medical supplies to support military healthcare programs worldwide. The underlying contract supports multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key supplier within DLA's broader strategy for pharmaceutical procurement across military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 9/10/25 |